AngioDynamics ANGO Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's deferred tax assets and other non-current assets?
- AngioDynamics (ANGO) reported deferred tax assets and other non-current assets of $10.5M in Q4 2025.
- How has AngioDynamics's deferred tax assets and other non-current assets changed year-over-year?
- AngioDynamics's deferred tax assets and other non-current assets increased by 8.4% year-over-year, from $9.68M to $10.5M.
- What is the long-term trend for AngioDynamics's deferred tax assets and other non-current assets?
- Over 4 years (2021 to 2025), AngioDynamics's deferred tax assets and other non-current assets has grown at a -5.8% compound annual growth rate (CAGR), from $13.19M to $10.4M.